These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protective action of fungicidin (nystatin) in mice against virulence enhancing activity of oxytetracycline on Candida albicans. HAZEN EL; BROWN R; MASON A Antibiot Chemother (Northfield); 1953 Nov; 3(11):1125-8. PubMed ID: 24542860 [No Abstract] [Full Text] [Related]
7. [Experimental studies on antifungal properties of nystatin]. TEDIAKINA AE; CHAIKOVSKAIA SM; BEREZINA EK Antibiotiki (Mosc); 1958; 3(3):40-5. PubMed ID: 24544901 [No Abstract] [Full Text] [Related]
8. RELEASE OF INTRACELLULAR CONSTITUENTS OF CANDIDA ALBICANS IN PRESENCE OF POLYENE ANTIBIOTICS. GHOSH A; GHOSH JJ Ann Biochem Exp Med; 1963 Dec; 23():611-26. PubMed ID: 14154207 [No Abstract] [Full Text] [Related]
9. Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans. BROWN R; HAZEN EL; MASON A Science; 1953 May; 117(3048):609-10. PubMed ID: 13056635 [No Abstract] [Full Text] [Related]
10. Sensitivity of Candida strains to nystatin. JENNISON RF; STENTON P J Clin Pathol; 1957 Aug; 10(3):219-21. PubMed ID: 13463110 [No Abstract] [Full Text] [Related]
11. [The problem of growth stimulation in Candida albicans by antibiotics]. MEYER-ROHN J; LANGE-BROCK T Arch Klin Exp Dermatol; 1957; 204(1):58-69. PubMed ID: 13403646 [No Abstract] [Full Text] [Related]
12. [Research on the effects of antibiotics on pathogenic fungi. II. Experiments on the effect of streptomycin on the behavior of Candida albicans and other dermatomycetes]. LEVI P Boll Ist Sieroter Milan; 1951; 30(11-12):674-9. PubMed ID: 14934834 [No Abstract] [Full Text] [Related]
13. [Fungicidal and antibacterial property of vitamin K5 (2-methyl-4-amino-1-naphthol HC1) combined with antibiotics. I. Antagonism and synergism in relation to Staphylococcus aureus, E. coli, B. pyocyaneum and Candida albicans]. MASONI S; ZULIANI F; NEPPI LEVI P Arch Sci Biol (Bologna); 1956; 40(1):38-46. PubMed ID: 13314907 [No Abstract] [Full Text] [Related]
14. Candida albicans infection of the skin and mucous membranes treated with nystatin. ROBINSON RC Antibiot Annu; 1955-1956; 3():851-5. PubMed ID: 13355375 [No Abstract] [Full Text] [Related]
15. [Further contribution to the interference exerted in vitro by Candida albicans on the antibacterial power of some antibiotics]. MASONI S; PAPINUTTO GP Nuovi Ann Ig Microbiol; 1955; 6(4):265-9. PubMed ID: 13288907 [No Abstract] [Full Text] [Related]
16. Pathogenesis of Candida albicans infection following antibiotic therapy. I. The effect of antibiotics on the growth of Candida albicans. HUPPERT M; MACPHERSON DA; CAZIN J J Bacteriol; 1953 Feb; 65(2):171-6. PubMed ID: 13034711 [No Abstract] [Full Text] [Related]
17. [Antibiotics as source of nitrogen for Candida albicans]. GRAM HG Zentralbl Bakteriol Orig; 1956 Jul; 166(3-4):199-205. PubMed ID: 13353544 [No Abstract] [Full Text] [Related]
18. In vitro experiments with Monilia and Escherichia coli to explain moniliasis in patients receiving antibiotics. PAINE TF Antibiot Chemother (Northfield); 1952 Dec; 2(12):653-8. PubMed ID: 24542156 [No Abstract] [Full Text] [Related]
19. The effect of certain antibiotics, antimalarial drugs and amebicides on Candida albicans. BECK O; LACY H Tex Rep Biol Med; 1951; 9(3):395-405. PubMed ID: 14866859 [No Abstract] [Full Text] [Related]
20. [Two cases of onychomycosis and perionychomycosis caused by Candida albicans, cured by mycostatin]. FAUCONNIER J Bull Soc Fr Dermatol Syphiligr; 1956; (2):136-8. PubMed ID: 13342785 [No Abstract] [Full Text] [Related] [Next] [New Search]